Requesting Chemical Probes G9a/GLP Selective Methyltransferase Inhibitor
UNC0638 was discovered through collaboration between the Structural Genomics Consortium (SGC) at the University of Toronto and the Center for Integrative Chemical Biology and Drug Discovery (CICBDD) at the University of North Carolina in Chapel Hill.
Sigma-Aldrich is now offering UNC0638 through their catalog. (Item U4885)
If you were supplied UNC0638 prior to the compound being available to the public from Sigma-Aldrich, please include "Peter J. Brown, Jian Jin, Chemical Probe Consortium" as authors in publications that made use of compound supplied by the Consortium, and list the following consortium contributors at the end of the paper. This publication strategy will properly acknowledge collaborators who contributed to the discovery of UNC0638, while not "diluting" the important contributions made by your group. If you believe that one or more of the consortium members has made a larger contribution to a publication, please list these authors in the primary author list, and remove them from the consortium list.
Dalia Barsyte-Lovejoy§, Masoud Vedadi§, Feng Liu‡, Xin Chen‡ Abdellah Allali-Hassani§, Alena Siarheyeva§, Tim J. Wigle‡, Gregory A. Wasney§, Aiping Dong§, Wolfram Tempel§, Irene Chau§, Jacqueline L. Norris‡, Dmitri B. Kireev‡, William P. Janzen‡, Aled M. Edwards§, Cheryl H. Arrowsmith§, Stephen V. Frye‡
§Structural Genomics Consortium, University of Toronto, ‡Center for Integrative Chemical Biology and Drug Discovery at the University of North Carolina at Chapel Hill.
The SGC and its scientists are committed to making their research outputs available without restriction on use and request the same commitment from collaborators: this means we have not filed for patent protection on the discovery or use of UNC0638, and we ask recipients of UNC0638 not to do so either. This ensures that all research investigators have freedom to use this compound for any research purpose.
